GT Biopharma, Inc. Business Operations Contracts & Agreements

20 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Voting Agreement Regarding Approval of GT Biopharma, Inc. Share Issuance under Securities Purchase Agreement
Voting Agreements
GT Biopharma, Inc.
Biotechnology
2025
Investigator Initiated Clinical Trial Agreement between Regents of the University of Minnesota and GT Biopharma, Inc.
Collaboration Agreements
GT Biopharma, Inc.
Biotechnology
MN
2024
Amendment No. 1 to Settlement and Investment Agreement between GT Biopharma, Inc. and Cytovance Biologics, Inc.
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
OK
2024
Board Service Agreement between GT Biopharma, Inc. and Michael Breen, dated January 12, 2021
Services Agreements
GT Biopharma, Inc.
Biotechnology
2021
Board Service Agreement between GT Biopharma, Inc. and Rajesh Shrotriya, Dated January 12, 2021
Services Agreements
GT Biopharma, Inc.
Biotechnology
2021
Board Service Agreement between GT Biopharma, Inc. and Gregory Berk (Director)
Services Agreements
GT Biopharma, Inc.
Biotechnology
2020
Board Service Agreement between GT Biopharma, Inc. and Bruce Wendel (Director)
Services Agreements
GT Biopharma, Inc.
Biotechnology
2020
Master Services Agreement between GT Biopharma, Inc. and Cytovance Biologics, Inc.
Services Agreements
GT Biopharma, Inc.
Biotechnology
DE
2020
Clinical Trial Agreement between GT Biopharma, Inc. and Regents of the University of Minnesota
Collaboration Agreements
GT Biopharma, Inc.
Biotechnology
MN
2020
Indemnification Agreement between GT Biopharma, Inc. and Director or Officer
Indemnification Agreements
GT Biopharma, Inc.
Biotechnology
DE
2018
Research Agreement between Oxis Biotech, Inc. and MultiCell Immunotherapeutics, Inc. (MCIT)
Collaboration Agreements
GT Biopharma, Inc.
Biotechnology
2015
Mutual Services Agreement between OXIS International, Inc. and Bio Check, Inc. dated June 23, 2006
Services Agreements
GT Biopharma, Inc.
Biotechnology
CA
2006
Settlement Agreement among Alto Opportunity Master Fund, GT Biopharma Inc., Anthony Cataldo, and Paul Kessler
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Settlement Agreement between GT Biopharma Inc. and Adam Kasower, East Ventures, SV Booth Investments III, and Theorem Group
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Settlement Agreement among Empery Funds, GT Biopharma Inc., Anthony Cataldo, and Paul Kessler
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
DE
2020
Settlement Agreement and Mutual General Release between OXIS International, Inc. and Bristol Investment Fund, Ltd. (August 8, 2012)
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
NY
2012
Advisory Agreement between Oxis International, Inc. and Gary M. Post
Advisory Agreements
GT Biopharma, Inc.
Biotechnology
CA
2010
Amendment to Advisory Agreement between Oxis International, Inc. and Ambient Advisors LLC
Advisory Agreements
GT Biopharma, Inc.
Biotechnology
2007
Advisory Agreement between Oxis International, Inc. and Ambient Advisors LLC dated November 6, 2006
Advisory Agreements
GT Biopharma, Inc.
Biotechnology
2006
Advisory Services Agreement between OXIS International, Inc. and Ambient Advisors, LLC
Advisory Agreements
GT Biopharma, Inc.
Biotechnology
2006